Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Use of compound P7C3-A20 in preparation of drug for treating cerebral ischemic diseases

A P7C3-A20, a technology for preparing medicines, which is applied in the application field of preparing medicines for treating cerebral ischemia, can solve the problem that there is no protective effect of P7C3-A20 on cerebral ischemic injury, and achieves reduction of cerebral infarction area and wide application. Prospects, the effect of improving the survival rate

Active Publication Date: 2015-10-28
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF5 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Currently, there is no report on the protective effect of P7C3-A20 on cerebral ischemic injury

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of compound P7C3-A20 in preparation of drug for treating cerebral ischemic diseases
  • Use of compound P7C3-A20 in preparation of drug for treating cerebral ischemic diseases
  • Use of compound P7C3-A20 in preparation of drug for treating cerebral ischemic diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] 1. Method

[0020] 1. Culture of mouse cerebral cortex neurons

[0021] (1) Pregnant mice were taken, E15-18 days, sacrificed by dislocation of the cervical spine, wiped the abdomen with 75% alcohol, laparotomy, and excised the uterus.

[0022] (2) Place the uterus in a petri dish containing double-antibody sterile deionized water, and transfer it to the cell room.

[0023] (3) Quickly transfer the uterus to ice-cold high-glucose DMEM, tear the uterus from the uterine horns with ophthalmic scissors, take out the fetal mouse, decapitate it with scissors, peel it off carefully, and take the brain; separate the cerebral cortex under a microscope and carefully peel it off meninges and blood vessels.

[0024] (4) Transfer the brain tissue into fresh ice-cold high-glucose DMEM, rinse twice, transfer to a 1.5mL EP tube, place it on ice, and cut the brain tissue as much as possible with curved scissors.

[0025] (6) Transfer the shredded brain tissue to a small Erlenmeyer fl...

Embodiment 2

[0040] 1. Method

[0041] Rats (Sprague-Dawley rats, weighing about 250 g, Shanghai Slack Experimental Animal Co., Ltd.) were used to prepare a permanent cerebral ischemic injury model. The process is as follows: rats were anesthetized, the skull was opened, and the middle cerebral artery was electrocoagulated directly under visual observation, resulting in blockage of the left middle cerebral artery. Thirty minutes later, rats were given intraperitoneal injection of P7C3-A20 (30 mg / kg). The skull was reset and the skin was sutured, and the rat model of permanent cerebral ischemia caused by occlusion of the middle cerebral artery was successfully prepared. Twenty-four hours after middle cerebral artery occlusion, the cerebral infarct area was detected. The volume of cerebral infarction was detected by 2,3,5-triphenyltetrazolium chloride (purchased from Amersco) staining method, that is, TTC staining method.

[0042] 2. Results

[0043] The results are shown in Table 1. It ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a use of a compound P7C3-A20 in preparation of a drug for treating cerebral ischemic diseases. A cell experiment proves that P7C3-A20 can improve a survival rate of mouse cerebral cortical neurons cultured in vitro in an oxygen-glucose deprivation model. An animal experiment proves that P7C3-A20 can obviously reduce the area of cerebral infarction caused by rat brain retinal artery occlusion. The above results show that P7C3-A20 has cerebral ischemia protection effects, can prevent and treat cerebral ischemia-caused brain damage and has a wide application prospect in preparation of cerebral ischemic injury and / or cerebral infarction-related drugs.

Description

technical field [0001] The present invention relates to a new application of the compound, in particular to the application of the compound P7C3-A20 in the preparation of a drug for treating cerebral ischemic diseases. Background technique [0002] P7C3-A20 is one of the P7C3 series compounds, the CAS number is 1235481-90-9, and the chemical structural formula is: [0003] [0004] It is a chloropropylcarbazole compound with high oral bioavailability, crosses the blood-brain barrier, and exhibits no toxicity at both effective and high doses. Foreign reports have found that P7C3 compounds have protective effects in depression, senile diseases such as Parkinson's (PD), amyotrophic lateral sclerosis (ALS), cognitive degenerative diseases, retinal degeneration and other diseases . At present, there is no report on the protective effect of P7C3-A20 on cerebral ischemic injury. Contents of the invention [0005] The purpose of the present invention is to provide a new appl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/403A61P9/10
Inventor 缪朝玉王培张赛龙王淑娜徐添颖管云枫
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com